Latest Headlines
-
AustinPx Partners With Microsize On KinetiSol® Technology
1/31/2024
AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, today announced the strategic partnership to accelerate the commercial application of AustinPx’s KinetiSol® Technology platform. The collaboration will enable AustinPx’s clients to manufacture their late-phase clinical and commercial KinetiSol drug product intermediate at Microsize’s purpose built, FDA-inspected facility.
-
AbbVie Announces $223 Million Investment For New Biologics Manufacturing Facility In Singapore
1/29/2024
AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.
-
INTEPRHEX Puts Hot-Topic Science In 2024 Event Registration Now Open | Event Program Now Online
1/22/2024
The reimagined INTERPHEX Conference is designed to bring attendees together to solve their business challenges and to understand the science that is shaping their industries.
-
Cleanroom Leader AES Clean Technology Announces New Chief Revenue Officer
1/18/2024
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
-
Single Use Support Continues To Grow, Expanding Its Team By 40%
1/17/2024
Innovative process solution provider Single Use Support continues to deliver strong organic growth, supported by an expansion in its employee base. With a successful year 2023 in the rear-view mirror, 2024 is already shaping up to be even better.
-
FUJIFILM Diosynth Biotechnologies And SHL Medical Enter Strategic Partnership Agreement To Help Meet Growing Market Demand For Autoinjector Medicines
1/8/2024
FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses today announced that it will expand its finished goods autoinjector services through a non-exclusive strategic partnership agreement with SHL Medical (SHL), a world-leading solutions provider of advanced drug delivery systems.
- Virtual Pharma Expo Announces 2024 Webinar Series Schedule 12/28/2023
-
Research Shows New Single-Use Protein A Capture Technology Offers 10X Productivity Over Standard Resin Columns For Antibody Purification
12/14/2023
AGC Biologics launched a new research paper from its global research and development Center (R&D Center). The R&D Study reveals the promise of new, simplified downstream technology capable of harvesting volumes of 2,000 L at titers ranging up to 10 g/L purification.
-
Nordson MEDICAL Unveils Pharma+ Tubing Retainers: A Breakthrough In Fluid Transfer Efficiency
12/1/2023
Nordson MEDICAL is proud to announce the launch of Pharma+ Tubing Retainers, a revolutionary addition to their product portfolio that promises to redefine excellence in fluid transfer applications.
-
Refeyn's New KaritroMP Quickly Analyzes Large Viral Vectors
11/30/2023
New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors within just minutes.